Ekaterina Krauss

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 490 citations · Full text

Antifibrotic Therapy, Advanced Lung Disease, Idiopathic Pulmonary Fibrosis +6

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis

Andreas Güenther, Ekaterina Krauss, Silke Tello et al. · Respiratory Research · 2018 · 243 citations · Full text

IL-9 and its receptor are predominantly involved in the pathogenesis of UC

N Nalleweg, Mircea T. Chiriac, Eva Podstawa et al. · Gut · 2014 · 176 citations

Relevance of Cor Pulmonale in COPD With and Without Pulmonary Hypertension: A Retrospective Cohort Study

Athiththan Yogeswaran, Stefan Kuhnert, Henning Gall et al. · Frontiers in Cardiovascular Medicine · 2022 · 64 citations · Full text

Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis

Sabine Witt, Ekaterina Krauss, María Asunción Nieto Barbero et al. · Respiratory Research · 2019 · 52 citations · Full text